Small Cell Lung Cancer Patients Can Benefit from Immunotherapy
The current standard of care for SCLC shows limited results with high toxicities. Drs. Soria, Gandhi, and West discuss new ASCO 2015 data that show promise for a subset of patients with PD-L1 expressi...
Author: cancergrace
Added: 07/01/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Immunotherapy | Lung Cancer | Small Cell Lung Cancer | Toxicology